DXR
Daxor Corp.

2,394
Mkt Cap
$68.38M
Volume
0.00
52W High
$14.00
52W Low
$6.55
PE Ratio
37.78
DXR Fundamentals
50D MA
$12.07
Beta
0.13
Avg. Volume
5,793.86
EPS (Annual)
$0.1108
P/B
1.93
Loading...
Loading...
DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
Sector:
Miscellaneous
Industry:
Investment Trusts Or Mutual Funds
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Daxor Corp.?
What is the 52-week high for Daxor Corp.?
What is the 52-week low for Daxor Corp.?
What is the PE ratio of Daxor Corp.?
What is the Price-to-Book ratio of Daxor Corp.?
What is the 50-day moving average of Daxor Corp.?

Latest DXR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.